Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand-Reference-Cited by-同舟云学术

Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand

Published:2023-08-09 Issue:9 Volume:46 Page:867-879
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Walton Muireann^ORCID,Pletzer Vadim^ORCID,Teunissen Thomas^ORCID,Lumley Thomas^ORCID,Hanlon Timothy^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

https://link.springer.com/content/pdf/10.1007/s40264-023-01332-1.pdf

Reference67 articles.

1. Ministry of Health New Zealand. COVID-19: Vaccines. 2022. https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-vaccines. Accessed 24 Jan 2022.

2. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–15. https://doi.org/10.1056/NEJMoa2034577.

3. Ministry of Health New Zealand. COVID-19 vaccines available in New Zealand. 2022. https://www.health.govt.nz/covid-19-novel-coronavirus/covid-19-vaccines/covid-19-vaccines-available-new-zealand. Accessed 5 Apr 2022.

4. Medsafe. COVID-19. Status of Application. Comirnaty (Pfizer-BioNTech): 12 years and older 2022. https://www.medsafe.govt.nz/COVID-19/status-of-applications.asp#Comirnaty12. Accessed 7 Feb 2022.

5. Medsafe. COVID-19. Status of Application. Comirnaty (Pfizer-BioNTech): 5 years and older 2022. https://www.medsafe.govt.nz/COVID-19/status-of-applications.asp#Comirnaty5. Accessed 7 Feb 2022.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of the scientific literature on experimental toxicity studies of COVID-19 vaccines, with special attention to publications in toxicology journals;Archives of Toxicology;2024-09-03

2. COVID-19 vaccine-associated myocarditis in an adolescent after the third vaccine dose. Case report with follow-up;Pediatria i Medycyna Rodzinna;2023-12-29

3. Pfizer-BioNTech COVID-19 vaccine increases risk of myocarditis/pericarditis;Reactions Weekly;2023-08-26